BiopharmaWatch
FDA/PDUFA Catalyst Calendar | Model Portfolios | Probability of Approval | Options, Earnings, Hedge Fund, and more. https://www.biopharmawatch #biotech #stocks
@biopharma_watch 1,692 X followersFirst product launched 3y ago
- Total monthly visits
- 14.6K
- Down15.4%MoMOct 2026
- Public revenue
- Undisclosed
- No public revenue across products
Traffic
Products
| Product | Visits · Oct | Actions |
|---|---|---|
| BiopharmaWatchMost actionable catalysts events for Biotech and Pharma investors | 14.6K |
Timeline
Nov 16 · Yesterday
BiopharmaWatch publishes Nov 16 pre-market biotech tapeReferrals & Backlinks
BiopharmaWatch posted “The Biotech Tape, Pre-Market” for Monday Nov 16. It reports CG Oncology up 30% on Phase 3 bladder cancer data and Helus down 28% despite positive Phase 3 results, with pre-market prices as of 8:30 AM ET.
Nov 1 · 16d ago
BiopharmaWatch Homepage headline (H1) changed to “Most actionable catalysts events for Biotech and Pharma investors”Positioning
Most actionable catalysts events for Biotech and Pharma investors→Most actionable catalysts events for Biotech and Pharma investors
BiopharmaWatch Removed technology: CloudflareFeatures
Cloudflare→—
BiopharmaWatch Removed technology: Cloudflare Bot ManagementFeatures
Cloudflare Bot Management→—
BiopharmaWatch Adopted technology: ExpressFeatures
—→Express
Questions & evidence
- What products has BiopharmaWatch built?
- BiopharmaWatch tracks 1 standalone software products on EarlyLore (1 currently live), led by BiopharmaWatch.
- How much website traffic do BiopharmaWatch's products get?
- Across tracked standalone domains with web traffic estimates, BiopharmaWatch's portfolio reaches 14.6K combined monthly visits in each site's latest observed month. Coverage excludes shared third-party hosts and store listings.
Related indie founder research guides
Evaluate your own SaaS idea →